by Clinical Neuropsychologist | Thursday, January 9, 2025 | Neuroimaging
ABSTRACT Background and Purpose Peak width of skeletonized mean diffusivity (PSMD) is a novel marker of white matter damage, which may be related to small vessel disease. This study aimed to investigate the presence of white matter damage in patients with isolated...
by Clinical Neuropsychologist | Thursday, January 9, 2025 | Neuroimaging
ABSTRACT Introduction The venous outflow profile (VOP) is a crucial yet often overlooked aspect affecting stroke outcomes. It plays a major role in the physiopathology of acute cerebral ischemia, as it accounts for both the upstream arterial collaterals and cerebral...
by Clinical Neuropsychologist | Thursday, January 9, 2025 | Dementia
Abstract INTRODUCTION Menopausal hormone therapy (MHT), along with the apolipoprotein E (APOE) ε4 allele, has been suggested as a possible risk factor for Alzheimer’s disease (AD). However, the relationship between MHT and cerebrospinal fluid (CSF) biomarkers is...
by Clinical Neuropsychologist | Thursday, January 9, 2025 | Dementia
Abstract Background The survival outcomes following an Alzheimer’s disease (AD) diagnosis hold significant importance for health management, caregivers, patients, and their families. Hawaii is known as the most diverse ethnic population in the United States and there...
by Clinical Neuropsychologist | Thursday, January 9, 2025 | Dementia
Abstract Background We analyzed the clinical care pathway of patients from symptom development to diagnosis at varying stages of Alzheimer’s disease (AD) to understand the path and barriers to diagnosis. Methods Data were from the US Adelphi Real World Dementia...
